No Detail Found!

Liqi Huoxue Dripping Pill protects ischemia and reperfusion-induced myocardial injury through mechanism involving inhibition of necroptosis in rat

Author(s)
Yaning Chen College of Clinical Medicine, Guizhou Medical University,Guian City,China;Department of Cardiology, Gui Zhou Provincial People's Hospital,Guiyang City,China
Lili Mo College of Clinical Medicine, Guizhou Medical University,Guian City,China
Xingde Liu College of Clinical Medicine, Guizhou Medical University,Guian City,China
Abstract
Liqi Huoxue Dripping Pill (LHDP), a traditional Chinese herbal formulation, has been shown in recent studies to possess cardioprotective effects. This study aimed to investigate the effects of LHDP on myocardial ischemiareperfusion injury (MIRI) in rats and their underlying mechanisms. MIRI model rats were administered varying doses of LHDP or Necrostin-1 (Nec-1s, an inhibitor of necroptosis) for 7 days. Echocardiography was performed to observe ventricular remodeling and systolic function. The infarct and fibrosis sizes were evaluated by pathological staining. The serum inflammatory factor levels were evaluated by enzyme-linked immunosorbent assay (ELISA). To investigate the effects of LHDP on necroptosis in I/R-treated hearts, we conducted analysis with quantitative real-time polymerase chain reaction (q-PCR) and Western blotting (WB). LHDP not only alleviated adverse ventricular remodeling and cardiac dysfunction induced by I/R, but also reduced inflammatory factor levels the serum levels of TNF-a, IL-6 and IL-1ß. Moreover, LHDP suppressed the expression of necroptosis-related molecules and these functions like Nec-1s. The study demonstrates that treatment with LHDP was conducive to reducing the inflammatory response and improving myocardial function following MIRI. The myocardial protective function of LHDP may be associated with the inhibition of necroptosis.
Publication Details
Page(s) 109-118
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
necroptosis, Chinese herbal drugs, Liqi Huoxue Dripping, ischemia and reperfusion-induced myocardial injury
References
Vaduganathan M,Mensah GA,Turco JV,Fuster V,Roth GA .2022 .The global burden of cardiovascular diseases and risk: A compass for future health. J. Am. Coll. Cardiol., 80(25) : 2361-2371.
Dauerman HL,Ibanez B .2021 .The edge of time in acute myocardial infarction. J. Am. Coll. Cardiol., 77(15) : 1871-1874.
Sabatine MS,Braunwald E,Am J. .2021 .Thrombolysis In Myocardial Infarction (TIMI) study group: JACC Focus Seminar 2/8. , 77(22) : 2822-2845.
Davidson SM,Ferdinandy P,Andreadou I,Bøtker HE,Heusch G,Ibáñez B,Ovize M,Schulz R,Yellon DM,Hausenloy DJ,Garcia-Dorado D .2019 .Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week. J. Am. Coll. Cardiol., 73(1) : 89-99.
Algoet M,Janssens S,Himmelreich U,Gsell W,Pusovnik M,Van Den Eynde M,Oosterlinck W .2023 .Myocardial ischemia-reperfusion injury and the influence of inflammation. Trends Cardiovasc. Med, 33(6) : 357-366.
Del Re DP,Amgalan D,Linkermann A,Liu Q,Kitsis RN .2019 .Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol. Rev., 99(4) : 1765-1817.
Maslov LN,Popov SV,Naryzhnaya NV,Mukhomedzyanov AV,Kurbatov BK,Derkachev IA,Boshchenko AA,Khaliulin I,Prasad NR,Singh N NR .2022 .The regulation of necroptosis and perspectives for the development of new drugs preventing ischemic/reperfusion of cardiac injury. , 27(9) : 697-719.
Ofengeim D Yuan J .2024 .A guide to cell death pathways. Nat. Rev. Mol. Cell Biol, 25(5) : 379-395.
Mu Cao L,W Cao L .2021 .Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications. Pharmacol Res., 163 : 105297.
Weisel K,Berger S,Papp K,Maari C,Krueger JG,Scott N,Tompson D,Wang S,Simeoni M,Bertin J,Peter Tak P J .2020 .Response to inhibition of receptorinteracting protein kinase 1 (RIPK1) in active plaque psoriasis: A randomized placebo-controlled study. Clin. Pharmacol, 108(4) : 808-816.
Munir I,Hassan Mehmood M,Faisal N,Hanif M,Naseer D M .2021 .Pharmacological evaluation of Vitis vinifera and Zingiber zerumbet on electrocardiographic, biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. Pak. J. Pharm. Sci., 34(5 Supplementary)) : 1929-1937.
Yang Q,Qian Z Q .2021 .Impacts of Yangxin decoction on the expressions of MMP-9, CaN, NFAT3 and GATA4 in myocardial tissue of rats with chronic heart failure. Pak. J. Pharm. Sci., 34 : 2059-2064.
Gao G,He Q,Chen X,Qian H,Yang R.,Liu C,Sun X,Li J .2018 .A randomized double-blind phase II clinical study on the treatment of coronary heart disease angina pectoris with Liqi Huoxue Dripping Pills. Chin. J. Evid-Based Cardiovasc. Med, 10(9) : 5.
Wang X,Zhang X,Wang T,Fan R,Dongyun XU,Zhao X,Hui XU,Huimei XU,Shen C,Xiao C C .2019 .Efficacy and safety of Liqi Huoxue Dripping Pill in the treatment of chronic stable angina pectoris: A prospective, one-arm,multi-center, Phase Ⅳ clinical trials. Chin. J. Integr. Med, 17(5) : 641-647.
Han Y,Wu ZG,Zhang XJ,Wang Q,Fan RH,Bi YX,Yu N,Wang XF .2021 .Efficacy and safety of Liqi Huoxue Dripping Pills in the treatment of elderly patients with chronic stable angina pectoris: A randomized controlled multicenter clinical study. Chin. J. Evid-Based Cardiovasc. Med, 13(2) : 5.
Zou CC,Mo LL,Zhou HY,Liu XD .2022 .Exploring the material basis and mechanism of Liqi Huoxue Dripping Pills in treating myocardial ischemiareperfusion injury based on network pharmacology. Stud. Trace Elem, 39(1) : 5.
Chen X,Yaofeng LI,Liu Y,Chen Y,Zhang Y,Jian XU,Yang C .2018 .Protective effect of miao medicine liqi huoxue dripping pills on chronic heart failure in rats. Chin. Pharm., 27(19) : 13-16.
Qiao S,Hong L,Zhu Y,Zha J,Wang A,Qiu J,Li W,Wang C,An J,Zhang H J .2022 .RIPK1-RIPK3 mediates myocardial fibrosis in type 2 diabetes mellitus by impairing autophagic flux of cardiac fibroblasts. Cell Death Dis., 13(2) : 147.
Mao H,Liu TJ,Yang CF,Li YF,Chen XY .2024 .The influence of Liqi Huoxue Dripping Pills on the transdifferentiation of isoprenaline-induced neonatal rat cardiac fibroblasts and its mechanism. Chin. J. Hosp. Pharm., 44(2) : 146-152.
Heusch G .2020 .Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol., 17(12) : 773-789.
Hadanny A,Shouval R,Wu J,Shlomo N,Unger R,Zahger D,Matetzky S,Goldenberg I,Beigel R,Gale C,Iakobishvili Z C .2021 .Predicting 30-day mortality after ST elevation myocardial infarction: Machine learning-based random forest and its external validation using two independent nationwide datasets. J. Cardiol., 78(5) : 439-446.
Muhammad I,Xiao YZ,Hassan SSU,Xiao X,Yan SK,Guo YQ,Ma XP,Jin HZ .2022 .Three new guaiane-type sesquiterpenoids and a monoterpenoid from Litsea lancilimba Merr. Nat. Prod. Res., 36(13) : 3271-3279.
Liao W,Ma X,Li J,Li X,Guo Z,Zhou S,Sun H S .2019 .A review of the mechanism of action of Dantonic(®) for the treatment of chronic stable angina. Biomed. Pharmacother, 109(3) : 690-700.
Gao GD,Li Jun,He QY Jun .2020 .Effectiveness and safety of Regulating-qi Activating-blood Liqi Huoxue Dripping Pills in treatment of stable angina pectoris of coronary heart disease. Chin. J. Evid-Based Cardiovasc. Med, 12(1) : 62-66.
Lin J,Hao Z,Ai J,Sun X .2019 .Therapeutic effect of Liqi Huoxue Dripping Pills on coronary heart disease of phlegm and blood stasis type in stable phase. Clin. J. Chin. Med, 11(30) : 36-39.
Jiang XN,Yuan W,Wang P,Gong QJ,Song XW .2023 .Clinical study on the treatment of unstable angina pectoris with Liqi Huoxue Dripping Pills combined with Atorvastatin. Mod. J. Integr. Tradit. Chin. West Med, 38(3) : 635-639.
Yao Y,Li F,Zhang M,Jin L,Xie P,Liu D,Zhang J,Hu X,Lv F,Shang H,Zheng W,Sun X,Duanmu J,Wu F,Lan F,Xiao RP,Zhang Y .2022 .Targeting CaMKII-δ9 Ameliorates cardiac ischemia/reperfusion injury by inhibiting myocardial inflammation. Circ. Res., 130(6) : 887-903.
Frangogiannis NG .2020 .Cardiac fibrosis. Cardiovasc Res, 117(6) : 1450-1488.
Meyer IS,Li X,Meyer C,Voloshanenko O,Pohl S,Boutros M,Katus HA,Frey N,Leuschner F .2022 .Blockade of Wnt secretion attenuates myocardial ischemia-reperfusion injury by modulating the inflammatory response. Int. J. Mol. Sci, 23(20) : 12252.
Xu T,Huang Q,Peng L,Zheng Y,Wu T,Lv D,Deng T,Mu C .2024 .The effect of Liqi Huoxue Drop on apoptosis of human umbilical vein endothelial cells loaded with low fluid shear stress through the YAP/TAZ-JNK signaling pathway. Shi Zhen Guo Yi Guo Yao., 35(9) : 2169-2173.
Newton K,Dixit VM,Kayagaki N VM .2021 .Dying cells fan the flames of inflammation. Science, 374(6571) : 1076-1080.
Ma D,Li Y,Zhu Y,Wei W,Zhang L,Li Y,Li L,Zhang L L .2021 .Cornel iridoid glycoside ameliorated Alzheimer's disease-like pathologies and necroptosis through RIPK1/MLKL pathway in young and aged SAMP8 mice. Evid. Based Complement. Alternat. Med, : 9920962.
Chen H,Tang LJ,Tu H,Zhou YJ,Li NS,Luo XJ,Peng J .2020 .Arctiin protects rat heart against ischemia/reperfusion injury via a mechanism involving reduction of necroptosis. Eur. J. Pharmacol., 875(17) : 30-53.
Huang B,Hu P,Hu A,Li Y,Shi W,Huang J,Jiang Q,Xu S,Li L,Wu Q .2019 .Naringenin attenuates carotid restenosis in rats after balloon injury through its anti-inflammation and anti-oxidative effects via the RIP1-RIP3-MLKL signaling pathway. Eur. J. Pharmacol., 855(2) : 167-174.
0

Citations

0

Downloads

159

Views